Biogen faces tough questions over $56K-a-year price of newly approved Alzheimer’s drug

Biogen on Tuesday faced tough questions from Wall Street analysts over the $56,000 annual cost of its newly approved Alzheimer’s drug, Aduhelm – a price tag executives are calling “fair” and “responsible.” Shares of Biogen surged 38% on Monday after the FDA announced it approved the company’s drug, scientifically known as aducanumab. It is the […]

Why Cassava Sciences Was Up 15% in May

What happened Shares of Cassava Sciences (NASDAQ:SAVA) rose 15% in May, according to data provided by S&P Global Market Intelligence. After a positive meeting with the Food and Drug Administration (FDA) in February, its treatment for Alzheimer’s Disease (AD) got more good news in May: It received a $2.7 million grant from the National Institutes of Health (NIH). So […]

Gold Slips as Yellen’s Inflation Comments Lift Treasury Yields

Gold declined as comments by Treasury Secretary Janet Yellen on inflation raised expectations for fiscal spending, pushing Treasury yields higher. Bullion ticked lower after Yellen said Sunday that President Joe Biden should push forward with his $4 trillion spending plans even if they trigger inflation that persists into next year, adding that a “slightly higher” […]

France fines Google $267 million for abusing ‘dominant position’ in online advertising

France’s competition watchdog has fined Google 220 million euros ($267 million) for abusing its market power in the online advertising industry. The French Competition Authority said Monday Google had unfairly sent business to its own services, and discriminated against the competition. Google has agreed to pay the fine and end some of its self-preferencing practices, […]